Cell therapy for neonatal hypoxia-ischemia and cerebral palsy

Annals of Neurology

Volumn 71, Issue 5, 2012, Pages 589-600

  Bennet, Laura ^a   Tan, Sidhartha ^b   Van Den Heuij, Lotte ^a   Derrick, Matthew ^b   Groenendaal, Floris ^c   Van Bel, Frank ^c   Juul, Sandra ^d   Back, Stephen A ^e   Northington, Frances ^f   Robertson, Nicola J ^g   Mallard, Carina ^h   Gunn, Alistair Jan ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; MAGNESIUM SULFATE; NEUROTROPHIC FACTOR; STROMAL CELL DERIVED FACTOR 1ALPHA; XENON;

ARTICLE; ASTROCYTE; AUTOLOGOUS CORD BLOOD CELL; BLOOD CELL; BRAIN INJURY; CANCER RISK; CELL DEATH; CELL DIFFERENTIATION; CELL HOMING; CELL MIGRATION; CEREBRAL PALSY; CLINICAL TRIAL (TOPIC); EMBRYONIC STEM CELL; HUMAN; HUMAN UMBILICAL CORD BLOOD CELL; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INDUCED HYPOTHERMIA; MATERNAL TREATMENT; MESENCHYMAL STEM CELL; MULTIPOTENT ASTROCYTIC STEM CELL; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NEWBORN DISEASE; NEWBORN HYPOXIA; NEWBORN HYPOXIC ISCHEMIC ENCEPHALOPATHY; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PLURIPOTENT STEM CELL; PREMATURITY; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TERATOMA; TREATMENT OUTCOME; UMBILICAL CORD;

ANIMALS; ANIMALS, NEWBORN; CEREBRAL PALSY; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; STEM CELL TRANSPLANTATION;

EID: 84860211612     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22670     Document Type: Article

References (78)

1. Kurinczuk JJ, White-Koning M, Badawi N,. Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev 2010; 86: 329-338.
2. Marlow N, Rose AS, Rands CE, Draper ES,. Neuropsychological and educational problems at school age associated with neonatal encephalopathy. Arch Dis Child Fetal Neonatal Ed 2005; 90: F380-F387.
3. Edwards AD, Brocklehurst P, Gunn AJ, et al. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. Br Med J 2010; 340: c363.
4. Gunn AJ, Bennet L,. Fetal hypoxia insults and patterns of brain injury: insights from animal models. Clin Perinatol 2009; 36: 579-593.
5. Bennet L, Roelfsema V, Pathipati P, et al. Relationship between evolving epileptiform activity and delayed loss of mitochondrial activity after asphyxia measured by near-infrared spectroscopy in preterm fetal sheep. J Physiol 2006; 572: 141-154.
6. Gunn AJ, Gunn TR, de Haan HH, et al. Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs. J Clin Invest 1997; 99: 248-256.
7. Jensen EC, Bennet L, Hunter CJ, et al. Post-hypoxic hypoperfusion is associated with suppression of cerebral metabolism and increased tissue oxygenation in near-term fetal sheep. J Physiol 2006; 572: 131-139.
8. Lorek A, Takei Y, Cady EB, et al. Delayed ("secondary") cerebral energy failure after acute hypoxia-ischemia in the newborn piglet: continuous 48-hour studies by phosphorus magnetic resonance spectroscopy. Pediatr Res 1994; 36: 699-706.
9. Roth SC, Baudin J, Cady E, et al. Relation of deranged neonatal cerebral oxidative metabolism with neurodevelopmental outcome and head circumference at 4 years. Dev Med Child Neurol 1997; 39: 718-725.
10. Colbourne F, Corbett D,. Delayed postischemic hypothermia: a six month survival study using behavioral and histological assessments of neuroprotection. J Neurosci 1995; 15: 7250-7260.
11. Geddes R, Vannucci RC, Vannucci SJ,. Delayed cerebral atrophy following moderate hypoxia-ischemia in the immature rat. Dev Neurosci 2001; 23: 180-185.
12. Stone BS, Zhang J, Mack DW, et al. Delayed neural network degeneration after neonatal hypoxia-ischemia. Ann Neurol 2008; 64: 535-546.
13. Barrett RD, Bennet L, Davidson J, et al. Destruction and reconstruction: hypoxia and the developing brain. Birth Defects Res C Embryo Today 2007; 81: 163-176.
14. Gunn AJ, Thoresen M,. Hypothermic neuroprotection. NeuroRx 2006; 3: 154-169.
15. Imperial College London. Neuroprotective effects of hypothermia combined with inhaled xenon following perinatal asphyxia (TOBYXe). Study NCT00934700, 2009. Available at: (accessed on 28 September 2011).
16. University of California, San Francisco. Neonatal erythropoietin in asphyxiated term newborns (NEAT). Study NCT00719407, 2011. Available at: (accessed on 28 September 2011).
17. Gunn AJ, Bennet L,. Brain cooling for preterm infants. Clin Perinatol 2008; 35: 735-748.
18. Committee Opinion No. 455: Magnesium sulfate before anticipated preterm birth for neuroprotection. Obstet Gynecol 2010; 115: 669-671.
19. Huusom LD, Secher NJ, Pryds O, et al. Antenatal magnesium sulphate may prevent cerebral palsy in preterm infants-but are we convinced? Evaluation of an apparently conclusive meta-analysis with trial sequential analysis. BJOG 2011; 118: 1-5.
20. Cord Blood Registry. 2011. Available at: (accessed on 16 April 2011).
21. Benekli M, Anderson B, Wentling D, et al. Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis. Bone Marrow Transplant 2000; 25: 1299-1301.
22. Sun J, Allison J, McLaughlin C, et al. Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders. Transfusion 2010; 50: 1980-1987.
23. Dressel R, Schindehutte J, Kuhlmann T, et al. The tumorigenicity of mouse embryonic stem cells and in vitro differentiated neuronal cells is controlled by the recipients' immune response. PloS One 2008; 3: e2622.
24. Zhao T, Zhang ZN, Rong Z, Xu Y,. Immunogenicity of induced pluripotent stem cells. Nature 2011; 474: 212-215.
25. Dressel R, Nolte J, Elsner L, et al. Pluripotent stem cells are highly susceptible targets for syngeneic, allogeneic, and xenogeneic natural killer cells. FASEB J 2010; 24: 2164-2177.
26. Laywell ED, Rakic P, Kukekov VG, et al. Identification of a multipotent astrocytic stem cell in the immature and adult mouse brain. Proc Natl Acad Sci U S A 2000; 97: 13883-13888.
27. Keene CD, Ortiz-Gonzalez XR, Jiang Y, et al. Neural differentiation and incorporation of bone marrow-derived multipotent adult progenitor cells after single cell transplantation into blastocyst stage mouse embryos. Cell Transplant 2003; 12: 201-213.
28. Rice JE III, Vannucci RC, Brierley JB,. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 1981; 9: 131-141.
29. Dobbing J, Sands J,. Comparative aspects of the brain growth spurt. Early Hum Dev 1979; 3: 79-83.
30. Romijn HJ, Hofman MA, Gramsbergen A,. At what age is the developing cerebral cortex of the rat comparable to that of the full-term newborn human baby? Early Hum Dev 1991; 26: 61-67.
31. Elsayed MH, Hogan TP, Shaw PL, Castro AJ,. Use of fetal cortical grafts in hypoxic-ischemic brain injury in neonatal rats. Exp Neurol 1996; 137: 127-141.
32. Jansen EM, Solberg L, Underhill S, et al. Transplantation of fetal neocortex ameliorates sensorimotor and locomotor deficits following neonatal ischemic-hypoxic brain injury in rats. Exp Neurol 1997; 147: 487-497.
33. Park KI, Hack MA, Ourednik J, et al. Acute injury directs the migration, proliferation, and differentiation of solid organ stem cells: evidence from the effect of hypoxia-ischemia in the CNS on clonal "reporter" neural stem cells. Exp Neurol 2006; 199: 156-178.
34. Imitola J, Raddassi K, Park KI, et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A 2004; 101: 18117-18122.
35. Zheng T, Rossignol C, Leibovici A, et al. Transplantation of multipotent astrocytic stem cells into a rat model of neonatal hypoxic-ischemic encephalopathy. Brain Res 2006; 1112: 99-105.
36. Sato Y, Nakanishi K, Hayakawa M, et al. Reduction of brain injury in neonatal hypoxic-ischemic rats by intracerebroventricular injection of neural stem/progenitor cells together with chondroitinase ABC. Reprod Sci 2008; 15: 613-620.
37. Daadi MM, Davis AS, Arac A, et al. Human neural stem cell grafts modify microglial response and enhance axonal sprouting in neonatal hypoxic-ischemic brain injury. Stroke 2010; 41: 516-523.
38. Ma J, Wang Y, Yang J, et al. Treatment of hypoxic-ischemic encephalopathy in mouse by transplantation of embryonic stem cell-derived cells. Neurochem Int 2007; 51: 57-65.
39. Park KI, Teng YD, Snyder EY,. The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat Biotechnol 2002; 20: 1111-1117.
40. Yasuhara T, Matsukawa N, Yu G, et al. Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury. Cell Transplant 2006; 15: 231-238.
41. Yasuhara T, Hara K, Maki M, et al. Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic-ischemic rats. J Cereb Blood Flow Metab 2008; 28: 1804-1810.
42. van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ,. Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration. Brain Behav Immun 2010; 24: 387-393.
43. van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ,. Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function. J Neurosci 2010; 30: 9603-9611.
44. van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ,. Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage. Pediatr Res 2010; 68: 419-422.
45. Lee JA, Kim BI, Jo CH, et al. Mesenchymal stem-cell transplantation for hypoxic-ischemic brain injury in neonatal rat model. Pediatr Res 2010; 67: 42-46.
46. Guan XQ, Yu JL, Li LQ, Liu GX,. Study on mesenchymal stem cells entering the brain through the blood-brain barrier [in Chinese]. Zhonghua Er Ke Za Zhi 2004; 42: 920-923.
47. Meier C, Middelanis J, Wasielewski B, et al. Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. Pediatr Res 2006; 59: 244-249.
48. Geissler M, Dinse HR, Neuhoff S, et al. Human umbilical cord blood cells restore brain damage induced changes in rat somatosensory cortex. PloS One 2011; 6: e20194.
49. Yasuhara T, Hara K, Maki M, et al. Mannitol facilitates neurotrophic factor up-regulation and behavioural recovery in neonatal hypoxic-ischaemic rats with human umbilical cord blood grafts. J Cell Mol Med 2010; 14: 914-921.
50. Pimentel-Coelho PM, Magalhaes ES, Lopes LM, et al. Human cord blood transplantation in a neonatal rat model of hypoxic-ischemic brain damage: functional outcome related to neuroprotection in the striatum. Stem Cells Dev 2010; 19: 351-358.
51. de Paula S, Vitola AS, Greggio S, et al. Hemispheric brain injury and behavioral deficits induced by severe neonatal hypoxia-ischemia in rats are not attenuated by intravenous administration of human umbilical cord blood cells. Pediatr Res 2009; 65: 631-635.
52. Escolar ML, Poe MD, Provenzale JM, et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med 2005; 352: 2069-2081.
53. Rizvanov AA, Kiyasov AP, Gaziziov IM, et al. Human umbilical cord blood cells transfected with VEGF and L(1)CAM do not differentiate into neurons but transform into vascular endothelial cells and secrete neuro-trophic factors to support neuro-genesis-a novel approach in stem cell therapy. Neurochem Int 2008; 53: 389-394.
54. van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ,. Mesenchymal stem cell transplantation changes the gene expression profile of the neonatal ischemic brain. Brain Behav Immun 2011; 25: 1342-1348.
55. Bliss TM, Andres RH, Steinberg GK,. Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis 2010; 37: 275-283.
56. Kassis I, Grigoriadis N, Gowda-Kurkalli B, et al. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch Neurol 2008; 65: 753-761.
57. Fainstein N, Vaknin I, Einstein O, et al. Neural precursor cells inhibit multiple inflammatory signals. Mol Cell Neurosci 2008; 39: 335-341.
58. Ben-Hur T,. Immunomodulation by neural stem cells. J Neurol Sci 2008; 265: 102-104.
59. Einstein O, Fainstein N, Vaknin I, et al. Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression. Ann Neurol 2007; 61: 209-218.
60. Borlongan CV, Hadman M, Sanberg CD, Sanberg PR,. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 2004; 35: 2385-2389.
61. Willing AE, Lixian J, Milliken M, et al. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J Neurosci Res 2003; 73: 296-307.
62. Zawadzka M, Lukasiuk K, Machaj EK, et al. Lack of migration and neurological benefits after infusion of umbilical cord blood cells in ischemic brain injury. Acta Neurobiol Exp (Wars) 2009; 69: 46-51.
63. Nystedt J, Makinen S, Laine J, Jolkkonen J,. Human cord blood CD34+ cells and behavioral recovery following focal cerebral ischemia in rats. Acta Neurobiol Exp (Warsz) 2006; 66: 293-300.
64. Makinen S, Kekarainen T, Nystedt J, et al. Human umbilical cord blood cells do not improve sensorimotor or cognitive outcome following transient middle cerebral artery occlusion in rats. Brain Res 2006; 1123: 207-215.
65. Moodley Y, Ilancheran S, Samuel C, et al. Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repair. Am J Respir Crit Care Med 2010; 182: 643-651.
66. Grigsby PL, Hirst JJ, Scheerlinck JP, et al. Fetal responses to maternal and intra-amniotic lipopolysaccharide administration in sheep. Biol Reprod 2003; 68: 1695-1702.
67. Nitsos I, Rees SM, Duncan J, et al. Chronic exposure to intra-amniotic lipopolysaccharide affects the ovine fetal brain. J Soc Gynecol Investig 2006; 13: 239-247.
68. Lu P, Jones LL, Snyder EY, Tuszynski MH,. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 2003; 181: 115-129.
69. Committee on Understanding Premature Birth and Assuring Healthy Outcomes. In:, Behrman RE, Butler AS, eds. Preterm birth: causes, consequences, and prevention. Washington DC: Institute of Medicine of the National Academies, 2007, pp. 346-397.
70. Miller SP, Ferriero DM, Leonard C, et al. Early brain injury in premature newborns detected with magnetic resonance imaging is associated with adverse early neurodevelopmental outcome. J Pediatr 2005; 147: 609-616.
71. Back SA, Luo NL, Mallinson RA, et al. Selective vulnerability of preterm white matter to oxidative damage defined by F2-isoprostanes. Ann Neurol 2005; 58: 108-120.
72. Noble M, Davies JE, Mayer-Proschel M, et al. Precursor cell biology and the development of astrocyte transplantation therapies: lessons from spinal cord injury. Neurotherapeutics 2011; 8: 677-693.
73. Volpe JJ,. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 2009; 8: 110-124.
74. Buser JR, Maire J, Riddle A, et al. Arrested pre-oligodendrocyte maturation contributes to myelination failure in premature infants. Ann Neurol. DOI: 10.1002/ana.22627, 2011.
75. Yager JY, Ashwal S,. Animal models of perinatal hypoxic-ischemic brain damage. Pediatr Neurol 2009; 40: 156-167.
76. Park KI, Himes BT, Stieg PE, et al. Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: evidence from engraftment of neurotrophin-3-expressing stem cells in hypoxic-ischemic brain injury. Exp Neurol 2006; 199: 179-190.
77. Qu SQ, Luan Z, Yin GC, et al. Transplantation of human fetal neural stem cells into cerebral ventricle of the neonatal rat following hypoxic-ischemic injury: survival, migration and differentiation [in Chinese]. Zhonghua Er Ke Za Zhi 2005; 43: 576-579.
78. Xia G, Hong X, Chen X, et al. Intracerebral transplantation of mesenchymal stem cells derived from human umbilical cord blood alleviates hypoxic ischemic brain injury in rat neonates. J Perinat Med 2010; 38: 215-221.